Last Updated: 02/12/2024
Novel vaccine technology to translate knowledge of immuno-pathogenesis into vaccines and therapeutics
Objectives
This project plans to conduct early phase trials of vaccines for Malaria and Streptococcus and to further understand how the immune system can be trained to control them.
Principal Institution
Principal Investigators / Focal Persons
Rationale and Abstract
Malaria and streptococcal diseases are collectively responsible for the loss of over 1,000,000 lives each year. The immune responses to the organisms responsible for these diseases have been studied and have used novel technology to develop candidate vaccines which are showing great promise in both pre-clinical and pilot stage human trials.
External reference
Themes
Date
Jan 2020 — Dec 2024
Total Project Funding
$1.04M
Funding Details
National Health and Medical Research Council (NHMRC) Australia, Australia
Grant ID: 1174091
AUD 1.5M
Country / Project Site(s)
Related Resources
